BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11556858)

  • 21. Synchronous and metachronous head and neck carcinomas.
    Schwartz LH; Ozsahin M; Zhang GN; Touboul E; De Vataire F; Andolenko P; Lacau-Saint-Guily J; Laugier A; Schlienger M
    Cancer; 1994 Oct; 74(7):1933-8. PubMed ID: 8082099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Squamous cell carcinoma of the head and neck in patients 40 years of age and younger.
    Benninger MS; Roberts JK; Levine HL; Wood BG; Tucker HM
    Laryngoscope; 1988 May; 98(5):531-4. PubMed ID: 3362015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-HPV-Related Head and Neck Squamous Cell Carcinoma in a Young Patient Cohort.
    Dougherty MI; Dougherty W; Kain JJ; Hughley BB; Shonka DC; Fedder KL; Jameson MJ
    Ear Nose Throat J; 2021 Dec; 100(10_suppl):1101S-1106S. PubMed ID: 32584613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
    Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonnasopharyngeal lymphoepithelioma of the head and neck.
    Dubey P; Ha CS; Ang KK; El-Naggar AK; Knapp C; Byers RM; Morrison WH
    Cancer; 1998 Apr; 82(8):1556-62. PubMed ID: 9554534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
    Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distant metastases in head and neck cancer.
    Duprez F; Berwouts D; De Neve W; Bonte K; Boterberg T; Deron P; Huvenne W; Rottey S; Mareel M
    Head Neck; 2017 Sep; 39(9):1733-1743. PubMed ID: 28650113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
    Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age as a prognostic factor for head and neck squamous cell carcinoma: should older patients be treated differently?
    Cinamon U; Hier MP; Black MJ
    J Otolaryngol; 2006 Feb; 35(1):8-12. PubMed ID: 16527009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin.
    Corry J; Bressel M; Fua T; Herschtal A; Solomon B; Porceddu SV; Wratten C; Rischin D
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):948-954. PubMed ID: 28483336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neck dissection for unknown cancer of the head and neck in the era of chemoradiation.
    Amsbaugh MJ; Yusuf M; Gaskins J; Silverman C; Potts K; Bumpous J; Redman R; Perez C; Dunlap N
    Am J Otolaryngol; 2017; 38(5):588-592. PubMed ID: 28633765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elderly patients with squamous cell carcinoma of the head and neck and the benefit of multimodality therapy.
    Moye VA; Chandramouleeswaran S; Zhao N; Muss HB; Weissler MC; Hayes DN; Zevallos JP
    Oncologist; 2015 Feb; 20(2):159-65. PubMed ID: 25582139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Type 2 Diabetes Mellitus on Survival in Head and Neck Squamous Cell Carcinoma.
    Foreman A; Lee DJ; McMullen C; de Almeida J; Muhanna N; Gama RR; Giuliani M; Liu G; Bratman SV; Huang SH; O'Sullivan B; Song Y; Xu W; Goldstein DP
    Otolaryngol Head Neck Surg; 2017 Oct; 157(4):657-663. PubMed ID: 28849730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of surgical resection on survival in patients with advanced head and neck cancer involving the carotid artery.
    Manzoor NF; Russell JO; Bricker A; Koyfman S; Scharpf J; Burkey B; Khan MJ
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1219-25. PubMed ID: 24077023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
    Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
    Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
    Soulières D; Faivre S; Mesía R; Remenár É; Li SH; Karpenko A; Dechaphunkul A; Ochsenreither S; Kiss LA; Lin JC; Nagarkar R; Tamás L; Kim SB; Erfán J; Alyasova A; Kasper S; Barone C; Turri S; Chakravartty A; Chol M; Aimone P; Hirawat S; Licitra L
    Lancet Oncol; 2017 Mar; 18(3):323-335. PubMed ID: 28131786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of transnasal endoscopy for screening of esophageal squamous cell carcinoma in high-risk patients: yield rate, completion rate, and safety.
    Wang CH; Lee YC; Wang CP; Chen CC; Ko JY; Han ML; Chen TC; Lou PJ; Yang TL; Hsiao TY; Wu MS; Wang HP; Tseng PH
    Dig Endosc; 2014 Jan; 26(1):24-31. PubMed ID: 23551305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.